national stem-cell therapy logo

Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz┬« Product

Creative Medical Technology Holdings

PHOENIX, April 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced progress in developing a reproducible clinical grade product of ImmCelz┬«. Multiple clinical experiments were performed in which […]